DARWIN BIOSCIENCES, INC.

Medtech · Private

Handheld, non-invasive lung cancer screening device using isothermal nucleic acid amplification and lateral flow readout for point-of-care detection of circulating tumor DNA biomarkers

Grants
$400K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
$299K
1 award · Health and Human S
#422 of 4531 in medtech
Patents
5
0 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Health and Human Services · Rapid Diagnostic Assays For Self-monitoring Of Acute Or Rebound HIV-1 Infection$299,408
Federal grantDepartment of Health and Human Services · Phase I · Point-of-need screening device for lung cancer in low-resource settings$399,998
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
419TheraNano LLC$300K—
420LIFETIME OMICS, INC.$300K—
421ESPER BIOSCIENCES INC$300K—
422DARWIN BIOSCIENCES, INC.$299K—
423SEVIDENT, INC.$299K—
424SALUS DISCOVERY LLC$299K—
425Focal Medical, Inc.$298K$6.4M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 5
  • Hand-held Device For Pre-symptomatic Detection Of Infectious Disease And Methods Of Use Thereofapplication
  • System And Apparatus For The Hand-held Amplification And Detection Of Nucleic Acidsapplication
  • Hand-held Device For Pre-symptomatic Detection Of Infectious Disease And Methods Of Use Thereofapplication
  • System And Apparatus For The Hand-held Amplification And Detection Of Nucleic Acidsapplication
  • System And Apparatus For The Hand-Held Amplification And Detection Of Nucleic Acidsapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.